Lung Neoplasm Malignant Clinical Trials
0 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Lung Neoplasm Malignant
Merck Sharp & Dohme LLC190 enrolled3 locationsNCT07286149
Recruiting
Phase 2
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
Lung Neoplasm Malignant
Merck Sharp & Dohme LLC60 enrolled31 locationsNCT06788912
Recruiting
Phase 2
Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors
Drug ResistanceMetastatic Solid CancersRadiotherapy+3 more
Chuangzhen Chen48 enrolled1 locationNCT07071103
Recruiting
Not Applicable
Benefit of Spectral Information in Patients Suspected for Lung Cancer
Lung Neoplasm Malignant
Copenhagen University Hospital at Herlev1,000 enrolled1 locationNCT06440616
Recruiting
Not Applicable
Confocal Laser Endomicroscopy VERification
Lung CancerLung Neoplasm Malignant
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)208 enrolled7 locationsNCT06079970
Recruiting
Not Applicable
Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer
Lung Neoplasm Malignant
Ruijin Hospital20 enrolled1 locationNCT04973293
Recruiting
MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
Lung Neoplasm Malignant
European Institute of Oncology270 enrolled2 locationsNCT05974475